Larvol Delta - Safety-and-Efficacy-in-Patients-With-Moderate-to-Severe-Subacute-and-Chronic-Atopic-Dermatitis

ADSTEM - EHL Bio

http://clinicaltrials.gov/ct2/show/NCT04137562

Mar 15, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next